UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2021 | 2022-02-16 | Future report Set alerts | |
| Q3 2021 | 2021-10-28 | 0.00 | 0.00 |
| Q2 2021 | 2021-07-28 | -0.14 | -0.14 |
| Q1 2021 | 2021-04-29 | 0.00 | 0.00 |
| Q4 2020 | 2021-02-18 | 0.09 | 0.09 |
| Q3 2020 | 2020-10-29 | 0.00 | 0.04 |
| Q2 2020 | 2020-07-30 | -0.10 | -0.10 |
| Q1 2020 | 2020-05-07 | -0.24 | -0.24 |
| Q4 2019 | 2020-02-20 | 0.09 | 0.09 |
| Q3 2019 | 2019-10-24 | 0.10 | 0.10 |
| 2016-04-29 | Downgrade | Robert W. Baird | Outperform to Neutral | $17.00 |
| 2016-04-28 | Reiterated Rating | Imperial Capital | Outperform | $17.00 to $18.50 |
| 2016-03-18 | Reiterated Rating | Stifel Nicolaus | Buy | $16.50 to $18.50 |
| 2016-02-19 | Lower Price Target | BB&T Corp. | Buy | $18.00 to $16.00 |
| 2016-02-18 | Lower Price Target | Imperial Capital | Outperform | $18.50 to $17.00 |
| 2016-02-18 | Upgrade | Stifel Nicolaus | Hold to Buy | $16.50 |
| 2016-02-18 | Lower Price Target | Raymond James | $19.00 to $18.50 | |
| 2016-02-18 | Lower Price Target | Credit Suisse | Neutral | $17.00 to $16.00 |
| 2016-02-18 | Lower Price Target | Raymond James Financial Inc. | $19.00 to $18.50 | |
| 2016-02-18 | Lower Price Target | Credit Suisse Group AG | Neutral | $17.00 to $16.00 |
| 2016-02-17 | Lower Price Target | Robert W. Baird | Outperform | $18.00 to $17.00 |
| 2016-02-16 | Lower Price Target | Barclays | Equal Weight | $17.00 to $16.00 |
| 2016-02-16 | Lower Price Target | Barclays PLC | Equal Weight | $17.00 to $16.00 |
| 2016-02-04 | Lower Price Target | Robert W. Baird | Outperform | $22.00 to $18.00 |
| 2016-01-20 | Reiterated Rating | Oppenheimer | Outperform | $21.00 to $20.00 |
| 2016-01-20 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $21.00 to $20.00 |
| 2015-12-30 | Reiterated Rating | Wedbush | Buy | |
| 2015-12-29 | Lower Price Target | Wedbush | Outperform | $23.00 to $21.00 |
| 2015-12-10 | Reiterated Rating | Imperial Capital | Outperform | $20.00 to $18.50 |
| 2015-12-07 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-12-02 | Initiated Coverage | Oppenheimer | Outperform | $21.00 |
| 2015-11-19 | Lower Price Target | Barclays | Equal Weight | $19.00 to $17.00 |
| 2015-11-06 | Initiated Coverage | Credit Suisse | Neutral | $18.00 |
| 2015-11-02 | Lower Price Target | BB&T Corp. | Buy | $20.00 |
| 2015-10-29 | Lower Price Target | Wedbush | $25.00 to $23.00 | |
| 2015-10-29 | Lower Price Target | Imperial Capital | Outperform | $24.00 to $20.00 |
| 2015-10-25 | Reiterated Rating | Robert W. Baird | Buy | |
| 2015-10-23 | Lower Price Target | Robert W. Baird | Outperform | $25.00 to $22.00 |
| 2015-10-19 | Lower Price Target | Macquarie | Neutral | $21.00 to $19.00 |
| 2015-10-08 | Lower Price Target | Wedbush | Outperform | $27.00 to $25.00 |
| 2015-10-01 | Reiterated Rating | Wedbush | Buy | $27.00 |
| 2015-07-20 | Reiterated Rating | Robert W. Baird | Outperform | $25.00 |
| 2015-07-09 | Reiterated Rating | Wedbush | Outperform | $26.00 |
| 2015-05-05 | Upgrade | Robert W. Baird | Neutral to Outperform | $23.00 to $25.00 |
| 2015-02-13 | Initiated Coverage | Imperial Capital | Buy | $24.00 |
| 2015-02-12 | Lower Price Target | Barclays | Equal Weight | $23.00 to $22.00 |
| 2015-01-06 | Lower Price Target | Barclays | Equal Weight | $24.00 to $23.00 |
| 2014-12-17 | Downgrade | Robert W. Baird | Outperform to Neutral | $23.00 |
| 2014-12-02 | Downgrade | Barclays | Overweight to Equal Weight | $24.00 |
| 2014-10-27 | Initiated Coverage | Macquarie | Neutral | $26.00 to $23.00 |
| 2014-10-24 | Reiterated Rating | Imperial Capital | Outperform | $23.50 to $24.00 |
| 2014-09-22 | Reiterated | Stifel | Buy | $24 to $25 |
| 2014-09-22 | Boost Price Target | Stifel Nicolaus | Buy | $24.00 to $25.00 |
| 2014-07-25 | Boost Price Target | Ardour Capital | Hold | $17.00 to $20.00 |
| 2014-07-24 | Reiterated Rating | Raymond James | Strong-Buy | $23.00 to $25.00 |
| 2014-07-24 | Upgrade | Imperial Capital | In-Line to Outperform | |
| 2014-06-11 | Boost Price Target | Imperial Capital | In-Line | $19.00 to $22.00 |
| 2014-06-11 | Reiterated Rating | Macquarie | Outperform | $21.00 to $25.00 |
| 2014-06-11 | Boost Price Target | Credit Suisse | Neutral | $19.00 to $22.00 |
| 2014-06-10 | Boost Price Target | Wunderlich | Buy | $22.00 to $24.00 |
| 2014-06-10 | Boost Price Target | Barclays | Overweight | $22.00 to $24.00 |
| 2014-05-21 | Initiated | BB&T Capital Mkts | Buy | $23 |
| 2014-05-21 | Initiated Coverage | BB&T Corp. | Buy | $23.00 |
| 2014-05-09 | Upgrade | Barclays | Equal Weight to Overweight | $20.00 to $22.00 |
| 2014-05-05 | Upgrade | Wedbush | Neutral to Outperform | $20.00 to $23.00 |
| 2014-04-24 | Reiterated Rating | Barclays | Equal Weight | $20.00 |
| 2014-04-24 | Reiterated Rating | Imperial Capital | In-Line | $19.50 |
| 2014-04-17 | Initiated Coverage | Macquarie | Outperform | $20.00 |
| 2014-03-31 | Upgrade | Raymond James | Outperform to Strong-Buy | $23.00 |
| 2014-03-26 | Upgrade | Robert W. Baird | Neutral to Outperform | $18.00 to $21.00 |
| 2014-03-03 | Upgrade | Ned Davis Research | Sell to Neutral | |
| 2013-11-22 | Initiated Coverage | Imperial Capital | In-Line | $19.00 |
| 2013-11-05 | Lower Price Target | Barclays | Equal Weight | $20.00 to $19.00 |
| 2013-10-25 | Lower Price Target | Wedbush | Neutral | $23.00 to $21.00 |
| 2013-10-25 | Downgrade | Ascendiant Capital Markets | Buy to Neutral | |
| 2013-10-22 | Lower Price Target | Barclays | Equal Weight | $21.00 to $20.00 |
| 2013-10-17 | Initiated Coverage | Stifel Nicolaus | Hold | |
| 2013-10-17 | Downgrade | Wedbush | Outperform to Neutral | $24.00 to $23.00 |
| 2013-10-14 | Downgrade | Raymond James | Strong-Buy to Outperform | $24.00 to $23.00 |
| 2013-02-08 | Downgrade | Ardour Capital | Accumulate to Hold | $21 |
| 2013-01-09 | Downgrade | Robert W. Baird | Outperform to Neutral | $20 |
| 2012-12-27 | Initiated | Capstone Investments | Buy | $23 |
| 2012-10-18 | Downgrade | Ardour Capital | Buy to Accumulate | $21 to $21 |
| 2012-03-13 | Initiated | KeyBanc Capital Mkts | Buy | $20 |
| 2012-03-06 | Upgrade | Barclays Capital | Equal Weight to Overweight | $18 to $20 |
| 2011-10-21 | Upgrade | Ardour Capital | Accumulate to Buy | $21 |
| 2009-10-16 | Downgrade | Oppenheimer | Outperform to Perform |
| 2016-04-29 | Downgrade | Robert W. Baird | Outperform to Neutral | $17.00 |
| 2016-04-28 | Reiterated Rating | Imperial Capital | Outperform | $17.00 to $18.50 |
| 2016-03-18 | Reiterated Rating | Stifel Nicolaus | Buy | $16.50 to $18.50 |
| 2016-02-19 | Lower Price Target | BB&T Corp. | Buy | $18.00 to $16.00 |
| 2016-02-18 | Lower Price Target | Imperial Capital | Outperform | $18.50 to $17.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CVA 36 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 3.19M |
| BlackRock Fund Advisors | 1.78M |
| ECOFIN LTD | 1.70M |
| PIONEER INVESTMENT MANAGEMENT INC | 1.30M |
| RHJ International SA | 0.58M |
| Daiwa SB Investments Ltd. | 0.58M |
| BlackRock Group LTD | 0.48M |
| Adirondack Funds | 0.29M |
| TEACHERS ADVISORS INC | 0.24M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.23M |
| ICC CAPITAL MANAGEMENT INC/ | 0.15M |
| Aperio Group, LLC | 0.13M |
| MANNING & NAPIER ADVISORS LLC | 0.10M |
| RUSSELL FRANK CO/ | 97079 |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 73336 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| SZ INVESTMENTS LLC | 1.55% (2027500) | CVA / |
| PATE WILLIAM | 0.31% (407177) | CVA / EXH / |
| Jones Stephen J President and CEO | 0.17% (226057) | APD / CVA / |
| ZELL SAMUEL | 0.11% (137663) | AXE / BXMT / CVA / CWH / ELS / EQR / |
| ORLANDO ANTHONY J President and CEO | 0.10% (135067) | CVA / LSTR / |
| Simpson Timothy Exec. VP, Gen\'l Counsel & Sec. | 0.10% (131501) | CVA / |
| Veenhof Derek Executive VP - Waste Solutions | 0.09% (122936) | CVA / |
| HOLSTEN JOSEPH M | 0.08% (102538) | CVA / LKQ / |
| SMITH JEAN | 0.08% (101784) | CVA / |
| SILBERMAN ROBERT S | 0.08% (100000) | CVA / FOXA / STRA / |
| Barse David Michael | 0.08% (98960) | CVA / |
| Khattri Sanjiv Executive VP & CFO | 0.07% (93834) | CVA / PAH / |
| Mulcahy Matthew SVP & Head of Corp Development | 0.06% (81563) | CVA / |
| BYNOE PETER C B | 0.06% (75122) | CVA / FTR / RELY / |
| Helgeson Bradford J Executive VP & CFO | 0.06% (72941) | CVA / |
| Klett John EVP & Chief Operating Officer | 0.06% (72849) | CVA / |
| de Castro Michael Joseph EVP Supply Chain | 0.05% (68008) | CVA / |
| Myones Seth Pres. Americas Covanta Energy | 0.05% (63988) | CVA / |
| Wright Michael A. SVP and Chief HR Officer | 0.04% (57268) | CVA / |
| Fisher Linda J. | 0.04% (46736) | CVA / |
| Stauder Paul E. President, Covanta Envir. Sol. | 0.04% (46347) | CVA / |
| BUCKS THOMAS VP and Chief Acctg Officer | 0.03% (44335) | CVA / |
| RANGER MICHAEL W | 0.03% (40000) | CVA / ED / |
| Zieselman Neil VP & Chief Accounting Officer | 0.01% (15910) | CVA / |
| Broglio Ronald J | 0.01% (15251) | CVA / |
| Grewal Manpreet VP & Chief Accounting Officer | 0.01% (14925) | CVA / |
UM